Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Delayed Graft Function

• Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant
• Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
• Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
• Envarsus in Delayed Graft Function (E-DGF)
• Better Evidence for Selecting Transplant Fluids
• RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function
• Renaparin® in Kidney Transplantation
• Heme Arginate in Transplantation Study
• Effect of Dexmedetomidine on Renal Function and Delayed Graft Function After Kidney Transplantation
• Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
• Volatile Anesthetic Protection Of Renal Transplants 2
• Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation
• Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation
• A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients
• QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
• Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant
• Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney
• Delayed Renal Allograft Function and Furosemide Treatment
• Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
• Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)
• C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
• Belatacept for Renal Transplant Recipients With Delayed Graft Function
• Belatacept in Kidney Transplantation of Moderately Sensitized Patients
• ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF
• Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation
• A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
• Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function
• Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function
• Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population
• Study on Delayed Graft Function Using Paired Kidneys
• A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
• Study to Improve Renal Function After Kidney Transplantation
• Tacrolimus to Sirolimus Conversion for Delayed Graft Function
• I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
• YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation
• Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
• Comparison of Sirolimus and Azathioprine in Lung Transplantation
• YSPSL for Prevention of Delayed Graft Function Part A
• YSPSL for Prevention of Delayed Graft Function Part B
• Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation
• An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
• A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
• Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)